Gilead Sciences Inc articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/07/22 16:09
2014/07/22 16:09
1m
There is more good news about HIV treatment pills used to prevent infection in people at high risk of getting the AIDS virus: Follow-up from a landmark study that proved the drug works now shows that...
2014/07/22 16:09
2014/07/22 16:09
Latest videos
2014/07/22 04:22
2014/07/22 04:22
11h
With all of these lofty expectations, I believe Gilead's actual results won't even matter. Wall Street is setting up the retail investing public for slaughter. My Gilead trade is a small bet short...
2014/07/21 12:58
2014/07/21 12:58
1d
Published: July 21, 2014 - 7:15 am When diners peruse the menu at Marc Murphy's acclaimed Landmarc restaurants, they won't find cheeses from around the world. About a year ago, Mr. Murphy attended an...
2014/07/20 15:06
2014/07/20 15:06
2d
Gilead Sciences Inc.’s (GILD) Solvadi, controversial because of its price, helps cure hepatitis C in people with HIV, according to researchers who say the drug has the potential to limit a top cause...
2014/07/15 17:06
2014/07/15 17:06
6d
Johnson & Johnson (JNJ)’s new hepatitis C drug Olysio is on the way to blockbuster sales in its first year, helping the drugmaker raise its 2014 earnings forecast for the second quarter in a...
2014/07/15 14:08
2014/07/15 14:08
7d
Johnson & Johnson (NYSE: JNJ) today announced sales of $19.5 billion for the second quarter of 2014, an increase of 9.1% as compared to the second quarter of 2013. Operational results increased 9.4%...
2014/07/15 12:55
2014/07/15 12:55
7d
Johnson & Johnson said Tuesday that its second-quarter earnings grew as sales of the company's new hepatitis C drug continued to boost the health-care giant's revenue. Sales of hepatitis C treatment...
2014/07/14 13:08
2014/07/14 13:08
8d
Today's headlines include coverage of Medicare, the health law and veterans' care policy issues as well as reports from the campaign trail. Kaiser Health News staff writer Mary Agnes Carey reports:...
2014/07/11 22:31
2014/07/11 22:31
10d
Two U.S. senators asked Gilead Sciences Inc. to produce documents explaining why its new hepatitis C drug is priced at $84,000, raising renewed concerns over the high costs to taxpayers. In a letter...
2014/07/10 06:07
2014/07/10 06:07
12d
Temasek Holdings Pte’s performance was helped by a S$5 billion ($4 billion) capital injection from Singapore’s Ministry of Finance, according to the state-owned investment firm’s annual...
2014/06/27 09:19
2014/06/27 09:19
25d
FOSTER CITY, Californie--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq : GILD) a annoncé aujourd’hui que la société a soumis une demande de nouveau médicament (NDA) auprès de l’agence japonaise des...
2014/06/27 07:17
2014/06/27 07:17
25d
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company has submitted a New Drug Application (NDA) to Japan’s Pharmaceutical and Medical Devices...
2014/06/24 05:06
2014/06/24 05:06
28d
In 14 months as Shire Plc’s (SHP) chief executive officer, Flemming Ornskov has cut costs, improved profit and made a series of acquisitions, establishing the company as a potential leader in rare...
2014/06/24 04:49
2014/06/24 04:49
28d
Health-care inflation has hit a low point and is poised to start rising again, but it’s unclear whether annual medical cost hikes are heading back to the double-digit increases of years past. That’s...
2014/06/23 10:31
2014/06/23 10:31
29d
... Staff & Wire Reports – Your Universe Online A new combination therapy could cut treatment time for hepatitis C to just four weeks, but quicker recovery comes with a steep price, as the new...
2014/06/20 14:22
2014/06/20 14:22
m
Patients are cared for at the emergency room at Jamaica Hospital is seen in New York, Monday,... Thank you for signing up for the Politics Today newsletter! You should receive your first newsletter...
2014/06/20 13:29
2014/06/20 13:29
m
... Merck is starting a tender offer on Friday to buy all of the outstanding shares of hepatitis C treatment maker Idenix Pharmaceuticals Inc. Merck & Co. announced earlier this month that it would pay...
2014/06/19 22:13
2014/06/19 22:13
m
WASHINGTON (AP) - Your money or your life? Sovaldi, a new pill for hepatitis C, cures the liver-wasting disease in 9 of 10 patients, but treatment can cost more than $90,000. Leading medical...
2014/07/22 16:09
2014/07/22 16:09
Latest from Twitter